In this report, both of GRP78 and CHOP protein levels were increased after treatment with tunicamycin in all tested cells including breast cancer cell lines and human normal cell lines (data not shown), indicating that tunicamycin-induced ER stress was not cell-type specific. The gene discussed is DDIT3; the disease is breast carcinoma.